Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huashanshen dropping pills for stable chronic obstructive pulmonary disease
ChiCTR2100044782Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Huashanshen dropping pills in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Pre-dose morning pulmonary function. Started Oct 2020; status: recruiting.
02
Drugs
Huashanshen dropping pills
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100044782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044782.